Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimas Echeverria

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Elife|April 2, 2024
Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitisKyounghee Min, Batuhan Yenilmez, Mark Kelly, et al.
Cell Reports|September 6, 2018
Nuclear Localization of Huntingtin mRNA Is Specific to Cells of Neuronal OriginMarie-Cécile Didiot, Chantal M Ferguson, Socheata Ly, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 14, 2021
An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitisBatuhan Yenilmez, Nicole Wetoska, Mark Kelly, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 11, 2016
Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA SilencingMarie-Cécile Didiot, Lauren M Hall, Andrew H Coles, et al.
Nucleic Acids Research|November 30, 2023
Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivoHan Zhang, Karen Kelly, Jonathan Lee, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Therapeutic delivery of albumin-binding siRNA targeting IRS2 to diverse cell types reduces mammary tumor growthClaire E Tocheny, Julianna E Buchwald, Christopher D Dahlke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2026
Therapeutic delivery of albumin-binding siRNA targeting IRS2 to diverse cell types reduces mammary tumor growthClaire E Tocheny, Julianna E Buchwald, Christopher D Dahlke, et al.
Nature Communications|October 3, 2022
Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in Huntington's disease modelsFaith Conroy, Rachael Miller, Julia F Alterman, et al.
Nucleic Acids Research|January 12, 2026
Presence of phosphodiester backbone, but not nucleobases, in the guide's 3' terminal region is necessary for RISC loading and target cleavage in vitro and in vivoDaniel O'Reilly, Raymond C Furgal, Vella M Ross, et al.
Research Square|July 3, 2023
Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy in vivoVignesh Narayan Hariharan, Jillian Caiazzi, Rachael Miller, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Elife|April 2, 2024
Lactate transporter MCT1 in hepatic stellate cells promotes fibrotic collagen expression in nonalcoholic steatohepatitisKyounghee Min, Batuhan Yenilmez, Mark Kelly, et al.
Cell Reports|September 6, 2018
Nuclear Localization of Huntingtin mRNA Is Specific to Cells of Neuronal OriginMarie-Cécile Didiot, Chantal M Ferguson, Socheata Ly, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 14, 2021
An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitisBatuhan Yenilmez, Nicole Wetoska, Mark Kelly, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 11, 2016
Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA SilencingMarie-Cécile Didiot, Lauren M Hall, Andrew H Coles, et al.
Nucleic Acids Research|November 30, 2023
Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivoHan Zhang, Karen Kelly, Jonathan Lee, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Therapeutic delivery of albumin-binding siRNA targeting IRS2 to diverse cell types reduces mammary tumor growthClaire E Tocheny, Julianna E Buchwald, Christopher D Dahlke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2026
Therapeutic delivery of albumin-binding siRNA targeting IRS2 to diverse cell types reduces mammary tumor growthClaire E Tocheny, Julianna E Buchwald, Christopher D Dahlke, et al.
Nature Communications|October 3, 2022
Chemical engineering of therapeutic siRNAs for allele-specific gene silencing in Huntington's disease modelsFaith Conroy, Rachael Miller, Julia F Alterman, et al.
Nucleic Acids Research|January 12, 2026
Presence of phosphodiester backbone, but not nucleobases, in the guide's 3' terminal region is necessary for RISC loading and target cleavage in vitro and in vivoDaniel O'Reilly, Raymond C Furgal, Vella M Ross, et al.
Research Square|July 3, 2023
Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy in vivoVignesh Narayan Hariharan, Jillian Caiazzi, Rachael Miller, et al.
Pageof 9